【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 7
List of Figures 9
Introduction 10
Global Markets Direct Report Coverage 10
Ulcerative Colitis Overview 11
Therapeutics Development 12
Pipeline Products for Ulcerative Colitis – Overview 12
Pipeline Products for Ulcerative Colitis – Comparative Analysis 13
Ulcerative Colitis – Therapeutics under Development by Companies 14
Ulcerative Colitis – Therapeutics under Investigation by Universities/Institutes 21
Ulcerative Colitis – Pipeline Products Glance 22
Late Stage Products 22
Clinical Stage Products 23
Early Stage Products 24
Unknown Stage Products 25
Ulcerative Colitis – Products under Development by Companies 26
Ulcerative Colitis – Products under Investigation by Universities/Institutes 33
Ulcerative Colitis – Companies Involved in Therapeutics Development 34
Ajinomoto Pharmaceuticals Co., Ltd. 34
AlphaMab Co., Ltd 35
Altheus Therapeutics, Inc. 36
Am-Pharma B.V. 37
Amgen Inc. 38
Astellas Pharma Inc. 39
AstraZeneca PLC 40
Athersys, Inc. 41
Atlantic Healthcare plc 42
Avaxia Biologics, Inc. 43
Biocon Limited 44
BioLineRx, Ltd. 45
Bristol-Myers Squibb Company 46
Celgene Corporation 47
Cellceutix Corporation 48
Celltrion, Inc. 49
ChemoCentryx, Inc. 50
ChironWells GmbH 51
Cosmo Pharmaceuticals S.p.A 52
Dr. Falk Pharma GmbH 53
Drais Pharmaceuticals, Inc. 54
Effimune SAS 55
Emergent BioSolutions Inc. 56
Enceladus Pharmaceuticals BV 57
Epirus Biopharmaceuticals, Inc. 58
Euroscreen S.A. 59
Farmacija d.o.o. Tuzla 60
Flexion Therapeutics, Inc. 61
Galapagos NV 62
Genentech, Inc. 63
Genfit SA 64
Genor BioPharma Co., Ltd. 65
Gilead Sciences, Inc. 66
GT Biologics Limited 67
GW Pharmaceuticals plc 68
iCo Therapeutics Inc. 69
InDex Pharmaceuticals AB 70
INOXIA Lifesciences GmbH 71
Invion Limited 72
Johnson & Johnson 73
Kaken Pharmaceutical Co., Ltd. 74
LIPID THERAPEUTICS GmbH 75
LTT Bio-Pharma Co., Ltd. 76
Mabion SA 77
Medestea Research & Production S.p.A. 78
Morphotek, Inc. 79
Nogra Pharma Limited 80
Oncobiologics, Inc. 81
Pfizer Inc. 82
Pluristem Therapeutics Inc. 83
ProtAb Ltd 84
Qu Biologics Inc. 85
Receptos, Inc. 86
Sandoz Inc. 87
Sanofi 88
Sigmoid Pharma Limited 89
Stelic Institute & Co. 90
sterna biologicals Gmbh & Co KG 91
Synergy Pharmaceuticals, Inc. 92
Takeda Pharmaceutical Company Limited 93
TiGenix NV 94
Tillotts Pharma AG 95
Trino Therapeutics Ltd 96
Vascular Biogenics Ltd. 97
Ventria Bioscience 98
Zyngenia, Inc. 99
Ulcerative Colitis – Therapeutics Assessment 100
Assessment by Monotherapy Products 100
Assessment by Combination Products 101
Assessment by Target 102
Assessment by Mechanism of Action 106
Assessment by Route of Administration 109
Assessment by Molecule Type 111
Drug Profiles 113
(mesalamine + N-acetylcysteine) – Drug Profile 113
(metenkefalin + tridecactide) – Drug Profile 115
AB-0045 – Drug Profile 116
abrilumab – Drug Profile 117
ABS-11 – Drug Profile 119
adalimumab biosimilar – Drug Profile 120
adalimumab biosimilar – Drug Profile 122
adalimumab biosimilar – Drug Profile 123
adalimumab biosimilar – Drug Profile 124
adalimumab biosimilar – Drug Profile 125
adalimumab biosimilar – Drug Profile 126
adalimumab biosimilar – Drug Profile 127
adalimumab biosimilar – Drug Profile 128
AJM-300 – Drug Profile 129
alicaforsen sodium – Drug Profile 131
Anatabine – Drug Profile 132
apremilast – Drug Profile 133
ASP-3291 – Drug Profile 136
AVX-470 – Drug Profile 137
AW/EPO-002 – Drug Profile 138
AW/EPO-003 – Drug Profile 139
AW/EPOPD-01 – Drug Profile 140
AW/EPOPD-02 – Drug Profile 141
AW/EPOPD-06 – Drug Profile 142
bertilimumab – Drug Profile 143
BL-7040 – Drug Profile 145
BLI-1006 – Drug Profile 148
brilacidin – Drug Profile 149
budesonide – Drug Profile 151
budesonide ER – Drug Profile 154
budesonide ER – Drug Profile 156
CCX-507 – Drug Profile 157
Cell Therapy for Ulcerative Colitis and Inflammatory Bowel Disease – Drug Profile 158
CNDO-201 – Drug Profile 159
Cx-602 – Drug Profile 161
cyclosporine CR – Drug Profile 162
DIMS-0150 – Drug Profile 163
Drugs for Ulcerative Colitis – Drug Profile 165
eldelumab – Drug Profile 166
enalaprilat – Drug Profile 168
ES-210 – Drug Profile 169
ESN-282 – Drug Profile 170
etrolizumab – Drug Profile 171
FX-003 – Drug Profile 173
GED-0507 – Drug Profile 174
GFT-505 – Drug Profile 175
GLPG-0974 – Drug Profile 178
GLPG-1205 – Drug Profile 179
GS-5745 – Drug Profile 180
GWP-42003 – Drug Profile 181
hyaluronate sodium – Drug Profile 183
IAC VITA – Drug Profile 184
infliximab – Drug Profile 186
infliximab biosimilar – Drug Profile 188
infliximab biosimilar – Drug Profile 190
infliximab biosimilar – Drug Profile 191
infliximab biosimilar – Drug Profile 192
INV-103 – Drug Profile 193
INV-88 – Drug Profile 195
KAG-308 – Drug Profile 196
KANAb-071 – Drug Profile 197
Leukothera – Drug Profile 198
Low Molecular Weight Heparin – Drug Profile 199
LT-0011 – Drug Profile 200
LT-02 – Drug Profile 201
MD-707 – Drug Profile 202
mesalamine – Drug Profile 203
mesalamine – Drug Profile 204
mesalamine CR – Drug Profile 205
mesalamine ER – Drug Profile 206
Monoclonal Antibodies to Antagonize Metallothioneins for Ulcerative Colitis and Crohn’s Disease – Drug Profile 208
Monoclonal Antibodies to Inhibit TNFR25 for Gastrointestinal Disorders and Asthma – Drug Profile 210
Monoclonal Antibody to Inhibit Ang-2 and TNF-a for Ulcerative Colitis, Arthritis and Inflammatory Disease – Drug Profile 211
Monoclonal Antibody to Inhibit CD3 for Autoimmune Disorders, CNS Disorders, Infectious Diseases, Liver Diseases, Metabolic Disorders and Cardiovascular Diseases – Drug Profile 212
MultiStem – Drug Profile 214
naltrexone – Drug Profile 217
Nanocort – Drug Profile 218
peficitinib – Drug Profile 220
Peptides to Inhibit IL-1 Beta for Ulcerative Colitis and Crohn’s Disease – Drug Profile 222
PF-00547659 – Drug Profile 223
PH-44 – Drug Profile 225
PH-46A – Drug Profile 226
PH-5 – Drug Profile 227
Prozumab – Drug Profile 228
QBECO – Drug Profile 229
Recombinant Human Alkaline Phosphatase – Drug Profile 231
Rosburix – Drug Profile 233
RPC-1063 – Drug Profile 234
SAR-252067 – Drug Profile 236
SB-012 – Drug Profile 237
SD-010 – Drug Profile 238
Small Molecule for Ulcerative Colitis and Inflammation – Drug Profile 239
Small Molecule to Agonize OP3 Receptor for Crohn’s Disease and Ulcerative Colitis – Drug Profile 240
Small Molecules for Gastrointestinal Disorders – Drug Profile 241
Small Molecules to Inhibit IL-13 for Ulcerative Colitis – Drug Profile 242
Small Molecules to Target IL-13 for Ulcerative Colitis – Drug Profile 243
SP-333 – Drug Profile 244
Stem Cell Therapy for Inflammatory Bowel Disease – Drug Profile 245
STNM-01 – Drug Profile 246
TAK-114 – Drug Profile 247
tofacitinib – Drug Profile 249
TP-10 – Drug Profile 253
VB-201 – Drug Profile 254
VEDA-1209 – Drug Profile 256
vedolizumab – Drug Profile 257
VEN-120 – Drug Profile 259
Ulcerative Colitis – Recent Pipeline Updates 260
Ulcerative Colitis – Dormant Projects 337
Ulcerative Colitis – Discontinued Products 340
Ulcerative Colitis – Product Development Milestones 342
Featured News & Press Releases 342
Appendix 350
Methodology 350
Coverage 350
Secondary Research 350
Primary Research 350
Expert Panel Validation 350
Contact Us 351
Disclaimer 351
【レポート販売概要】
■ タイトル：潰瘍性大腸炎(Ulcerative Colitis)の治療薬パイプライン動向（2015年上半期版）■ 英文：Ulcerative Colitis - Pipeline Review, H1 2015
■ 発行日：2015年1月22日
■ 調査会社：Global Markets Direct
■ 商品コード：GMDHC6015IDB
■ 調査対象地域：グローバル
- バンカー燃料の世界市場：種類別、地域別Global Bunker Fuel Market: About this market Technavio’s bunker fuel market analysis considers sales from high sulfur fuel and low sulfur fuel types. Our study also finds the sales of bunker fuel in APAC, Europe, MEA, North America, and South America. In 2019, the low sulfur fuel segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such a …
- ARゲームの世界市場2017-2021About AR Gaming The first stage of AR began in the late 1950s when Sensorama was invented. The machine was similar to a mini theater that would engage all five senses and create an immersive experience at the cinema. Since the invention of Sensorama, many ideas that could enable people to interact with their environment have come up. One such is the virtual reality (VR) technology that creates a s …
- Northern Petroleum Plc：石油・ガスの開発・生産動向及びコスト分析- 2012Northern Petroleum Plc Oil & Gas Exploration and Production Operations and Cost Analysis - 2012 Summary Northern Petroleum Plc Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source f …
- Nigeriaの炭酸カリウム市場：貿易（輸入、輸出）動向This market research report examines the foreign trade of Nigeria and its perspectives on the global market for Potassium carbonates. The report will be of considerable interest primarily to relevant strategic planners, senior company officials and importers/exporters, since it features invaluable information on Potassium carbonates export/import operations in Nigeria. The 2002-2012 period is cove …
- 建設用複合材料の世界市場予測：ガラス繊維、天然繊維、炭素繊維、バサルト繊維The global construction composites market is projected to reach USD 6.65 Billion by 2021, at a CAGR of 5.80%, during the forecast period, 2016 and 2021. The increase in the penetration of construction composites in the construction industry, the long life & low maintenance requirement, rapid urbanization & economic boom in the emerging countries and the development of innovative products, are key …
- 防水膜の世界市場分析：製品別（ポリマー、瀝青、ポリマー改質セメント）、用途別（液体塗布膜、シートメンブレン）、エンドユーザー別（屋根、壁、建築物、埋立地およびトンネル）、セグメント予測Global waterproofing membranes market is expected to reach USD 9.49 billion by 2022, according to a new study by Grand View Research, Inc. Increased infrastructural investments by U.S., India and China is expected to propel market growth over the forecast period. In addition, improving infrastructure in developing countries of Central & South America and Asia Pacific has been a key contributing fa …
- ダークチョコレートの世界市場2015-2019About Dark Chocolate Dark chocolate is made from cocoa butter, sugar, and cocoa powder, with very little or no milk. Dark chocolates are considered very beneficial for health. The introduction of new varieties has increased sales. New varieties contain ingredients such as dry fruits, toffee, and sea salt. Increased demand for dark chocolate in developing countries is a result of rise in income lev …
- 血液検査の世界市場：技術（核酸増幅検査（NAT）、ELISA法、EIA法、CLIA法、次世代シーケンシング、ウエスタンブロット法）、試薬、装置The blood screening market size is expected to reach $2.55 billion by 2019 from $1.5 billion in 2014, at a CAGR of 10.4%. This market is categorized on the basis of products and services, technologies, end users, and regions. On the basis of products and services, the blood screening market is categorized into instruments (hardware), reagents, and software and services. The reagents segment accoun …
- 胸腰椎手術器具の世界市場2018-2022About Thoracolumbar Spine Devices Thoracolumbar spine devices are implants that aid in the treatment of several diseases such as degenerative disc disease (DDD), spinal stenosis, disc herniation, spinal instability or scoliosis, excessive kyphosis, and prolapsed intervertebral disc among others. Technavio’s analysts forecast the Global Thoracolumbar Spine Devices Market to grow at a CAGR of 3.78% …
- コールドチェーンの世界市場：冷蔵倉庫、冷蔵輸送Global Cold Chain Market: About this market A cold chain is a type of supply chain that consists of transportation and storage of temperature-sensitive perishable goods. Technavio’s cold chain market analysis considers sales from meat, fish, and seafood, dairy and frozen desserts, fruits, vegetables, and beverages cold, bakery and confectionery, and healthcare applications. Our analysis also consi …
- 株式売買ソフトウェアの世界市場2016-2020About the Stock Market Software Industry Trading software helps analyze the trading of financial products such as stocks and currencies. This software is usually developed by brokerage firms to meet the specific needs of their clients. It helps brokerage firms to manage client accounts through the internet. Stock market software provides a powerful analysis and in-depth comparison of stocks, enabl …
- ケアマネジメントソリューションの世界市場予測（～2021）The care management solutions market is projected to reach USD 15.70 Billion by 2021 from USD 6.93 Billion in 2016, growing at a CAGR of 17.8%. Factors such as the implementation of initiatives to shift the burden of risk from payers to providers, legislations and initiatives to promote ‘patient-centeredness’ in healthcare, rising geriatric population coupled with the burden of chronic diseases, n …
- 欧州の産業用ロボット市場2016-2020About Industrial Robotics Industrial robots consist of a robotic arm, control cabinet, control panel, and other peripherals. They are used for welding, painting, pick and place, palletizing, cutting, assembly, and product testing, and inspection. These robots are often used to perform tasks that are repetitive, laborious, and dangerous. Technavio’s analysts forecast the European industrial robotic …
- Italian HIV/AIDS Diagnostics Market 2014: Hospitals, Blood Banks, Commercial Labs–Supplier Shares and Sales Forecasts For Immunodiagnostic and NAT ProceduresComplete report $2,300. DataPack (test volumes, sales forecasts, supplier shares) $1,500.Summary This report presents detailed analyses of the AIDS diagnostics market in Italy. The report provides test volume and sales forecasts for HIV-1/2, HIV Ag, NAT, Western Blot and other confirmatory tests performed in the following market segments: - Hospitals …
- イベント管理ソフトウェアの世界市場2015-2019About Event Management as a Service Event management software is used for managing and coordinating professional and academic conferences, exhibitions, and shows. Its applications include online registration, online payment, venue selection, procurement, sourcing, paper management, exhibition management, content management, and booking and billing. The software also enables on-site operations such …
